Regulating Il9 transcription in T helper cells

Trends in Immunology

Volumn 32, Issue 4, 2011, Pages 146-150

  Perumal, Narayanan B ^a   Kaplan, Mark H ^b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 9; TRANSCRIPTION FACTOR;

CELL DIFFERENTIATION; CELL FUNCTION; EPIGENETICS; GENE CONTROL; GENETIC TRANSCRIPTION; HELPER CELL; HUMAN; NONHUMAN; PHENOTYPE; PLASTICITY; PROTEIN EXPRESSION; REVIEW;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-9; T-LYMPHOCYTES, HELPER-INDUCER; TRANSCRIPTION, GENETIC;

EID: 79953096442     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2011.01.006     Document Type: Review

References (50)

1. Schmitt E., et al. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J. Immunol. 1994, 153:3989-3996.
2. Chang H.C., et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 2010, 11:527-534.
3. Dardalhon V., et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat. Immunol. 2008, 9:1347-1355.
4. Veldhoen M., et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 2008, 9:1341-1346.
5. Goswami R., Kaplan M.H. A Brief History of IL-9. J. Immunol. 2011, 186:3283-3288.
6. Noelle R.J., Nowak E.C. Cellular sources and immune functions of interleukin-9. Nat. Rev. Immunol. 2010, 10:683-687.
7. Stassen M., et al. p38 MAP kinase drives the expression of mast cell-derived IL-9 via activation of the transcription factor GATA-1. Mol. Immunol. 2007, 44:926-933.
8. Chang H.C., et al. PU.1 regulates TCR expression by modulating GATA-3 activity. J. Immunol. 2009, 183:4887-4894.
9. Chang H.C., et al. PU.1 expression delineates heterogeneity in primary Th2 cells. Immunity 2005, 22:693-703.
10. Staudt V., et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 2010, 33:192-202.
11. Ahyi A.N., et al. IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines. J. Immunol. 2009, 183:1598-1606.
12. Brustle A., et al. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 2007, 8:958-966.
13. Lohoff M., et al. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:11808-11812.
14. Ovcharenko I., et al. ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res. 2004, 32:W280-W286.
15. Loots G.G., Ovcharenko I. rVISTA 2. 0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res. 2004, 32:W217-W221.
16. Bryne J.C., et al. JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update. Nucleic Acids Res. 2008, 36:D102-D106.
17. Escalante C.R., et al. Crystal structure of PU.1/IRF-4/DNA ternary complex. Mol. Cell 2002, 10:1097-1105.
18. Stassen M., et al. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J. Immunol. 2001, 166:4391-4398.
19. Zhu Y.X., et al. Multiple transcription factors are required for activation of human interleukin 9 gene in T cells. J. Biol. Chem. 1996, 271:15815-15822.
20. Gessner A., et al. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 1993, 189:419-435.
21. Takimoto T., et al. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development. J. Immunol. 2010, 185:842-855.
22. Murphy E., et al. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 1996, 183:901-913.
23. Bending D., et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 2009, 119:565-572.
24. Lee Y.K., et al. Late developmental plasticity in the T helper 17 lineage. Immunity 2009, 30:92-107.
25. Martin-Orozco N., et al. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur. J. Immunol. 2009, 39:216-224.
26. Mathur A.N., et al. T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. Blood 2006, 108:1595-1601.
27. Shi G., et al. Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells. J. Immunol. 2008, 181:7205-7213.
28. Lexberg M.H., et al. IFN-gamma and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells. Eur. J. Immunol. 2010, 40:3017-3027.
29. Lexberg M.H., et al. Th memory for interleukin-17 expression is stable in vivo. Eur. J. Immunol. 2008, 38:2654-2664.
30. Stritesky G.L., et al. IL-23 promotes maintenance but not commitment to the Th17 lineage. J. Immunol. 2008, 181:5948-5955.
31. Mukasa R., et al. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 2010, 32:616-627.
32. Wei G., et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009, 30:155-167.
33. King I.L., Mohrs M. IL-4-producing CD4+ T cells in reactive lymph nodes during helminth infection are T follicular helper cells. J. Exp. Med. 2009, 206:1001-1007.
34. Reinhardt R.L., et al. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat. Immunol. 2009, 10:385-393.
35. Zaretsky A.G., et al. T follicular helper cells differentiate from Th2 cells in response to helminth antigens. J. Exp. Med. 2009, 206:991-999.
36. Adeeku E., et al. Flexibility accompanies commitment of memory CD4 lymphocytes derived from IL-4 locus-activated precursors. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9307-9312.
37. Hegazy A.N., et al. Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity 2010, 32:116-128.
38. Acosta-Rodriguez E.V., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007, 8:639-646.
39. Ivanov I.I., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
40. Liu X., et al. Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases. J. Immunol. 2008, 180:6070-6076.
41. Annunziato F., et al. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007, 204:1849-1861.
42. Cosmi L., et al. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J. Allergy Clin. Immunol. 2010, 125:222-230.
43. Wang Y.H., et al. A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J. Exp. Med. 2010, 207:2479-2491.
44. Ghoreschi K., et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 2010, 467:967-971.
45. Elyaman W., et al. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:12885-12890.
46. Nowak E.C., et al. IL-9 as a mediator of Th17-driven inflammatory disease. J. Exp. Med. 2009, 206:1653-1660.
47. Tan C., et al. Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site. J. Immunol. 2010, 185:6795-6801.
48. Jager A., et al. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 2009, 183:7169-7177.
49. Stritesky G.L., et al. The transcription factor STAT3 is required for T helper 2 cell development. Immunity 2011, 34:39-49.
50. Zhu J., et al. Stat5 activation plays a critical role in Th2 differentiation. Immunity 2003, 19:739-748.